Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.

Qu L, Lemon SM.

Semin Liver Dis. 2010 Nov;30(4):319-32. doi: 10.1055/s-0030-1267534. Epub 2010 Oct 19. Review.

PMID:
20960373
2.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

3.

EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.

Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, Chung RT.

J Virol. 2015 Jul;89(13):6608-18. doi: 10.1128/JVI.00364-15. Epub 2015 Apr 15.

4.

Innate and adaptive immune responses in HCV infections.

Heim MH, Thimme R.

J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. Review.

5.

MDA5 plays a critical role in interferon response during hepatitis C virus infection.

Cao X, Ding Q, Lu J, Tao W, Huang B, Zhao Y, Niu J, Liu YJ, Zhong J.

J Hepatol. 2015 Apr;62(4):771-8. doi: 10.1016/j.jhep.2014.11.007. Epub 2014 Nov 21.

PMID:
25463548
6.

Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.

Brownell J, Wagoner J, Lovelace ES, Thirstrup D, Mohar I, Smith W, Giugliano S, Li K, Crispe IN, Rosen HR, Polyak SJ.

J Hepatol. 2013 Oct;59(4):701-8. doi: 10.1016/j.jhep.2013.06.001. Epub 2013 Jun 12.

7.

Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.

Fensterl V, Grotheer D, Berk I, Schlemminger S, Vallbracht A, Dotzauer A.

J Virol. 2005 Sep;79(17):10968-77.

8.

Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.

Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, Li K, Lemon SM.

PLoS Pathog. 2011 Sep;7(9):e1002169. doi: 10.1371/journal.ppat.1002169. Epub 2011 Sep 8.

9.

Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Breiman A, Grandvaux N, Lin R, Ottone C, Akira S, Yoneyama M, Fujita T, Hiscott J, Meurs EF.

J Virol. 2005 Apr;79(7):3969-78.

10.

Multi-step regulation of interferon induction by hepatitis C virus.

Oshiumi H, Funami K, Aly HH, Matsumoto M, Seya T.

Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):127-38. doi: 10.1007/s00005-012-0214-x. Epub 2013 Jan 5. Review.

PMID:
23292079
11.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
12.

Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.

Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J.

Gastroenterology. 2011 Aug;141(2):674-85, 685.e1-6. doi: 10.1053/j.gastro.2011.04.060. Epub 2011 May 6.

13.

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Israelow B, Narbus CM, Sourisseau M, Evans MJ.

Hepatology. 2014 Oct;60(4):1170-9. doi: 10.1002/hep.27227. Epub 2014 Aug 21.

14.

Antiviral innate immunity pathways.

Seth RB, Sun L, Chen ZJ.

Cell Res. 2006 Feb;16(2):141-7. Review.

15.

Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III-independent pathways.

Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S.

J Virol. 2010 Nov;84(21):11350-8. doi: 10.1128/JVI.01106-10. Epub 2010 Aug 25.

16.

Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.

Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM.

Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7253-8. Epub 2007 Apr 16.

17.

Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.

Mitchell AM, Stone AE, Cheng L, Ballinger K, Edwards MG, Stoddard M, Li H, Golden-Mason L, Shaw GM, Khetani S, Rosen HR.

MBio. 2015 Feb 24;6(2):e02510. doi: 10.1128/mBio.02510-14.

18.

Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.

Kell A, Stoddard M, Li H, Marcotrigiano J, Shaw GM, Gale M Jr.

J Virol. 2015 Nov;89(21):11056-68. doi: 10.1128/JVI.01964-15. Epub 2015 Aug 26.

19.

Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Li K, Chen Z, Kato N, Gale M Jr, Lemon SM.

J Biol Chem. 2005 Apr 29;280(17):16739-47. Epub 2005 Feb 28.

20.

NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase.

Vegna S, Gregoire D, Moreau M, Lassus P, Durantel D, Assenat E, Hibner U, Simonin Y.

J Virol. 2016 Jun 10;90(13):6022-6035. doi: 10.1128/JVI.03230-15. Print 2016 Jul 1.

Supplemental Content

Support Center